Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia

Summary. According to the modern concept, leukemic stem cells (LSC) in acute myeloid leukemia (AML) are distinct from the bulk of leukemic cells in bone marrow and peripheral blood of AML patients. Nevertheless, LSC are responsible for managing all the hierarchy of the bulk of leukemic blast populat...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2023
Автори: Ivanivska, T.S., Sklyarenko, L.M., Zavelevich, M.P., Philchenkov, A.A., Koval, S.V., Polishchuk, A.S., Gluzman, D.F.
Формат: Стаття
Мова:English
Опубліковано: PH Akademperiodyka 2023
Теми:
Онлайн доступ:https://exp-oncology.com.ua/index.php/Exp/article/view/2019-3-8
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Experimental Oncology

Репозитарії

Experimental Oncology
id oai:ojs2.ex.aqua-time.com.ua:article-235
record_format ojs
spelling oai:ojs2.ex.aqua-time.com.ua:article-2352023-10-11T16:41:40Z Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia Ivanivska, T.S. Sklyarenko, L.M. Zavelevich, M.P. Philchenkov, A.A. Koval, S.V. Polishchuk, A.S. Gluzman, D.F. acute myeloid leukemia., bulk of blast cells, hematopoiesis, hematopoietic stem cells, leukemic stem cells, targeted therapy acute myeloid leukemia., bulk of blast cells, hematopoiesis, hematopoietic stem cells, leukemic stem cells, targeted therapy Summary. According to the modern concept, leukemic stem cells (LSC) in acute myeloid leukemia (AML) are distinct from the bulk of leukemic cells in bone marrow and peripheral blood of AML patients. Nevertheless, LSC are responsible for managing all the hierarchy of the bulk of leukemic blast populations. This mini-review provides brief information on the distinctive features of LSC and blast cells in cytologically recognized types of AML. The study of different phenotypes of LSC and blast cells in AML with the aid of up-to-date flow cytometric techniques is important both for the deep insight into the mechanisms of leukemogenesis and development of novel strategies of target therapy. The urgent need for extending the diagnostic panel of monoclonal antibodies used for diagnosing AML is beyond doubt. Summary. According to the modern concept, leukemic stem cells (LSC) in acute myeloid leukemia (AML) are distinct from the bulk of leukemic cells in bone marrow and peripheral blood of AML patients. Nevertheless, LSC are responsible for managing all the hierarchy of the bulk of leukemic blast populations. This mini-review provides brief information on the distinctive features of LSC and blast cells in cytologically recognized types of AML. The study of different phenotypes of LSC and blast cells in AML with the aid of up-to-date flow cytometric techniques is important both for the deep insight into the mechanisms of leukemogenesis and development of novel strategies of target therapy. The urgent need for extending the diagnostic panel of monoclonal antibodies used for diagnosing AML is beyond doubt. PH Akademperiodyka 2023-06-04 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2019-3-8 10.32471/exp-oncology.2312-8852.vol-41-no-3.13492 Experimental Oncology; Vol. 41 No. 3 (2019): Experimental Oncology; 207-209 Експериментальна онкологія; Том 41 № 3 (2019): Експериментальна онкологія; 207-209 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-41-no-3 en https://exp-oncology.com.ua/index.php/Exp/article/view/2019-3-8/2019-3-8 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/
institution Experimental Oncology
baseUrl_str
datestamp_date 2023-10-11T16:41:40Z
collection OJS
language English
topic acute myeloid leukemia.
bulk of blast cells
hematopoiesis
hematopoietic stem cells
leukemic stem cells
targeted therapy
spellingShingle acute myeloid leukemia.
bulk of blast cells
hematopoiesis
hematopoietic stem cells
leukemic stem cells
targeted therapy
Ivanivska, T.S.
Sklyarenko, L.M.
Zavelevich, M.P.
Philchenkov, A.A.
Koval, S.V.
Polishchuk, A.S.
Gluzman, D.F.
Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
topic_facet acute myeloid leukemia.
bulk of blast cells
hematopoiesis
hematopoietic stem cells
leukemic stem cells
targeted therapy
acute myeloid leukemia.
bulk of blast cells
hematopoiesis
hematopoietic stem cells
leukemic stem cells
targeted therapy
format Article
author Ivanivska, T.S.
Sklyarenko, L.M.
Zavelevich, M.P.
Philchenkov, A.A.
Koval, S.V.
Polishchuk, A.S.
Gluzman, D.F.
author_facet Ivanivska, T.S.
Sklyarenko, L.M.
Zavelevich, M.P.
Philchenkov, A.A.
Koval, S.V.
Polishchuk, A.S.
Gluzman, D.F.
author_sort Ivanivska, T.S.
title Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
title_short Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
title_full Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
title_fullStr Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
title_full_unstemmed Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
title_sort immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
title_alt Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
description Summary. According to the modern concept, leukemic stem cells (LSC) in acute myeloid leukemia (AML) are distinct from the bulk of leukemic cells in bone marrow and peripheral blood of AML patients. Nevertheless, LSC are responsible for managing all the hierarchy of the bulk of leukemic blast populations. This mini-review provides brief information on the distinctive features of LSC and blast cells in cytologically recognized types of AML. The study of different phenotypes of LSC and blast cells in AML with the aid of up-to-date flow cytometric techniques is important both for the deep insight into the mechanisms of leukemogenesis and development of novel strategies of target therapy. The urgent need for extending the diagnostic panel of monoclonal antibodies used for diagnosing AML is beyond doubt.
publisher PH Akademperiodyka
publishDate 2023
url https://exp-oncology.com.ua/index.php/Exp/article/view/2019-3-8
work_keys_str_mv AT ivanivskats immunophenotypicfeaturesofleukemicstemcellsandbulkofblastsinacutemyeloidleukemia
AT sklyarenkolm immunophenotypicfeaturesofleukemicstemcellsandbulkofblastsinacutemyeloidleukemia
AT zavelevichmp immunophenotypicfeaturesofleukemicstemcellsandbulkofblastsinacutemyeloidleukemia
AT philchenkovaa immunophenotypicfeaturesofleukemicstemcellsandbulkofblastsinacutemyeloidleukemia
AT kovalsv immunophenotypicfeaturesofleukemicstemcellsandbulkofblastsinacutemyeloidleukemia
AT polishchukas immunophenotypicfeaturesofleukemicstemcellsandbulkofblastsinacutemyeloidleukemia
AT gluzmandf immunophenotypicfeaturesofleukemicstemcellsandbulkofblastsinacutemyeloidleukemia
first_indexed 2025-07-17T12:16:51Z
last_indexed 2025-07-17T12:16:51Z
_version_ 1837896420549459968